Stay updated on Olaparib in BRCA Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib in BRCA Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.4 to v3.6.5, indicating a newer build of the site. This is a maintenance/update rather than a change to study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-08-11T08:13:39.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The study record now displays the most recent update dates, indicating routine maintenance to refresh the record. These changes are metadata about maintenance rather than substantive updates to the study design, results, or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-08-04T06:53:19.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, reflecting a small update to the page metadata.
    Difference
    0.0%
    Check dated 2026-07-28T05:16:20.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision bumped from v3.6.2 to v3.6.3 on the page, indicating a software update. The study content and visible information for NCT01874353 appear unchanged.
    Difference
    0.0%
    Check dated 2026-07-06T16:32:38.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    A new bibliographic citation was added documenting the adverse-event profile in BRCA-mutated, platinum-sensitive relapsed ovarian cancer (SOLO2 trial) from Int J Gynecol Cancer, 2026. The page revision tag was updated from v3.6.0 to v3.6.2.
    Difference
    0.0%
    Check dated 2026-06-29T08:44:44.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The Study Details page now includes user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment notice stating 'No longer looking for participants.' The Intervention/Treatment heading has been standardized (replacing 'Intervention / Treatment'), and the page footer revision label updated from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T05:20:09.000Z thumbnail image

Stay in the know with updates to Olaparib in BRCA Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.